Publications scientifiques sur les diagnostics non invasifs BioPredictive

Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.

8/435 Résultats pour
“chronic obstructive pulmonary disease”

“chronic obstructive pulmonary disease” Tout effacer
  1. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

    Viglino D et al. · Eur Respir J · 2017 Score 100

    …fat, common features of chronic obstructive pulmonary disease (COPD), might contribute to…

    FibroTest NashTest SteatoTest Metabolic

  2. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

    Viglino D et al. · Sci Rep · 2018 Score 94

    Chronic Obstructive Pulmonary Disease (COPD) and Non-Alcoholic Fatty Liver Disease (NAFLD…

    FibroTest NashTest SteatoTest Metabolic

  3. Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations.

    Monneret D · F1000Res · 2017 Score 88

    …to be evidenced in chronic obstructive pulmonary disease (COPD). Recently, Viglino _et…

    FibroTest NashTest SteatoTest Metabolic

  4. Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.

    Natarajan Y et al. · Dig Dis Sci · 2017 Score 82

    …determinants of mortality in many chronic diseases. The extent to which survival…

    FibroTest HCV

  5. Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.

    Poynard T et al. · Hepatol Commun · 2023 Score 75

    FibroTest Other

  6. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

    Sadler MD et al. · Can J Gastroenterol Hepatol · 2015 Score 69

    ### Background Liver disease is the third leading cause of mortality in patients…

    FibroTest Other

  7. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19. Key publication

    Deckmyn O et al. · Biomedicines · 2022 Score 63

    In patients with non-alcoholic fatty liver disease (NAFLD) with or without…

    FibroTest Metabolic

  8. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

    · 2014 Score 57

    These are the first guidelines dealing with hepatitis C treatment produced by…

    FibroTest HCV

Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.